Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 248 resources
-
Shooting Up: infections among people who inject drugs in the UK, 2019
Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.UK, England, Northern Ireland, Scotland, Wales 28 Jan 2021 Reports & Research PDF -
Northern Ireland Hepatitis C Elimination Plan
This Northern Ireland Department of Health and Public Health Agency action plan sets out the approach to eliminating hepatitis C in Northern Ireland by 2025, five years ahead of the World Health Organization 2030 target.Northern Ireland 20 Jan 2021 Reports & Research, Strategy & Planning PDF -
Cost-effectiveness of opt-out HCV and HBV testing in A&E in the UK
Research published in Value in Health in December 2020 found that testing for hepatitis C and hepatitis B in A&E departments in the UK is highly likely to be cost effective due to high rates of hepatitis among people who attend A&E. Based on a study of two London hospitals, the paper argues that, just as NICE guidelines recommend testing people attending A&E for HIV, hepatitis C and hepatitis B testing should also occur.UK 22 Dec 2020 Reports & Research PDF -
The impact of the COVID-19 pandemic on prevention, testing, diagnosis and care for sexually transmitted infections, HIV and viral hepatitis in England
This Public Health England report covers the findings of analyses of the impact of the COVID-19 pandemic response on sexually transmitted infection (STI), HIV and viral hepatitis service provision and epidemiology. Despite a resurgence in hepatitis C testing and treatment initiations from June 2020, testing and treatment initiations in the summer of 2020 were considerably lower than in corresponding months in 2019. The report notes that "HCV testing through traditional venues may not have reached those in greatest need", describing this is "of particular concern".England 17 Dec 2020 Reports & Research PDF -
Hepatitis C testing and treatment interventions for the homeless population in London during the Covid-19 pandemic: Outcomes and learning
This report from the London Joint Working Group on Substance Use and Hepatitis C outlines the outcomes and learnings of hepatitis C testing and treatment interventions for the homeless population during the Covid-19 pandemic. The report reveals that over 1,000 people were tested for blood-borne viruses over the course of 98 testing events in London between May and August 2020. Of those tested, 11% were positive for hepatitis C antibodies and 7% had an active infection.England, Greater London 17 Dec 2020 Reports & Research PDF -
Public Health England Hepatitis C in the UK 2020 Report
Public Health England published its annual 'Hepatitis C in the UK' report on 14th December 2020. This is the key national reporting document for hepatitis C and monitors the UK's progress towards its goal of eliminating the virus by 2030. This year's report includes details on the impact of COVID-19 on hepatitis C infection based on available data.UK, England, Northern Ireland, Scotland, Wales 14 Dec 2020 Reports & Research PDF -
Summary report: Hepatitis C in the justice system - going beyond prisons
This report summarises the presentations and discussions from the HCV Action webinar, 'Hepatitis C in the justice system - going beyond prisons', held on Friday 23rd October as part of the National Hepatitis C ODN Stakeholder Webinar series. The event focused in particular on providing support around hepatitis C for those making the transition from prison to the community.UK 17 Nov 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF -
Summary report: National Hepatitis C ODN Stakeholder Event 2020
Eighteen months on from the start of NHS England’s hepatitis C elimination deal, HCV Action’s annual ODN event, co-hosted with the British Viral Hepatitis Group, explored how the UK has progressed towards elimination. It particularly focused on overcoming the challenges posed by the significant disruption of Covid-19 on healthcare services. This year’s event was held as a half-day webinar due to coronavirus-related restrictions and welcomed 129 participants from almost all ODNs and partner services.England 30 Oct 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF -
Summary report: Hepatitis C case-finding in under-served groups - October 2020
This report summarises the October 2020 HCV Action webinar on hepatitis C case-finding in under-served groups, which formed part of a week-long series of webinars centred around the National Hepatitis C ODN Stakeholder Event. The webinar focused on four under-served groups in particular: Gypsy, Roma and Travellers; migrants; sex-workers, and the South Asian community. The webinar featured contributions from the following speakers: • Beth Davies – Head of Service and Development (Dorset), EDP Drug & Alcohol Services • Dr Inês Campos-Matos – Head of Migration Health, Public Health EnglandUK 22 Oct 2020 Reports & Research PDF -
A glossary of contested terms in substance use
This is a glossary of terms used by people working in the drugs field, drawn up by the Scottish Drugs Forum. It covers some of the specialised and contentious language used in the field. We have included it in the resource library as it may be helpful to those who work in health services who are less familiar with some of the language and terms used by colleagues and partners in drug services.UK 07 Oct 2020 Training, Reports & Research PDF